New Stem Cell Therapy Which Mimics How Salamanders Grow New Limbs Raises Hopes of New Regenerative Treatments
5th April 2016
Therapies based on “induced multipotent stem” (iMS) cells could be tested in human trials as early as next year, according to Australian researchers.
The team, from the University of New South Wales, demonstrated a way of producing iMS cells by reprogramming bone and fat cells.
…
Unlike other kinds of stem cell that can differentiate into many types of tissue, iMS cells are not thought to run the risk of triggering cancer.
Lead scientist Professor John Pimanda, said: “We are currently assessing whether adult human fat cells reprogrammed into iMS cells can safely repair damaged tissue in mice, with human trials expected to begin in late 2017.